Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma

The treatment options for metastatic non-small-cell lung cancer (NSCLC) have expanded dramatically in the last 10 years with the discovery of newer drugs and targeted therapy. Epidermal growth factor receptor (EGFR), when aberrantly activated, promotes cell growth and contributes in various ways to...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Manish K, Wozniak, Antoinette J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342611/
https://www.ncbi.nlm.nih.gov/pubmed/28293124
http://dx.doi.org/10.2147/LCTT.S104207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342611/
https://www.ncbi.nlm.nih.gov/pubmed/28293124
http://dx.doi.org/10.2147/LCTT.S104207

Ejemplares similares